The Department of Health and Social Care (DH) has extended a medicine supply notification issued for Trifluoperazine 1mg/5ml syrup of Advanz Pharma.
Trifluoperazine 1mg/5ml syrup will remain out of stock until late July.
Earlier, Trifluoperazine 1mg/5ml syrup was estimated to remain out of stock until April, 2021.
However, Trifluoperazine 1mg and 5mg tablets remain available and is expected to support an increase in demand.
Trifluoperazine 5mg/5ml oral solution is also available and can support an increase in demand.
Specials manufacturers have confirmed they can manufacture trifluoperazine 1mg/5ml oral suspension.
“When prescribing a product that is not licensed in the UK prescribers must indicate on the FP10 prescription that an unlicensed product is required. This can be done by annotating the prescription with the following wording: special order,” the Pharmaceutical Services Negotiating Committee (PSNC) said.
There is currently no listing on dm+d for the imported product for prescribers to select using their prescribing systems. Where a prescriber wishes to prescribe an unlicensed import, a paper prescription should be issued as ‘Trifluoperazine 1mg/5ml oral suspension (Special Order)‘ and endorsed by the pharmacy as a non-Part VIIIB special.
